Maleic Acid

Maleic Acid

SCHEMBL2213373

C=C(CC)C(=O)O.O=C(O)/C=C\C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
TP53 P04637 1/20 0.45
EGLN1 Q9GZT9 1/20 0.45
EGLN3 Q9H6Z9 1/20 0.45
HCAR2 Q8TDS4 6/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TET2 Q6N021 3/20 0.37
FFAR3 O14843 1/20 0.36
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7520083 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL7518651 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL4270106 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL7518661 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Crotonic Acid SCHEMBL27711584 0.89 ALOX15 (0.39) TSHRTP53EGLN1EGLN3HCAR2
Crotonic Acid SCHEMBL28123858 0.87 ALOX15 (0.38) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL4891196 0.87 ALOX15 (0.38) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL17865 0.87
SCHEMBL156659 0.87 FFAR3 (0.47) TSHRTP53ALOX15HSD17B10TET2
Acrylic Acid SCHEMBL28411354 0.85 ALOX15 (0.60) TSHRTP53ALOX15HSD17B10TET2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2082082-B1 MULTI-COMPONENT FIBERS CONTAINING HIGH CHAIN-LENGTH POLYAMIDES ARKEMA INC (US) 2011-07-27 EP disclosed
US-20100062669-A1 MULTI-COMPONENT FIBERS CONTAINING HIGH CHAIN-LENGTH POLYAMIDES ARKEMA INC. (US) 2010-03-11 US disclosed
EP-1562621-B1 COMPOSITION FOR TREATING ICHTHYOSIS USING ANTITRYPSIN ARRIVA PROMETIC INC (CA) 2009-08-19 EP disclosed
EP-2082082-A2 MULTI-COMPONENT FIBERS CONTAINING HIGH CHAIN-LENGTH POLYAMIDES Arkema Inc. (US) 2009-07-29 EP disclosed
WO-2008060830-A2 MULTI-COMPONENT FIBERS CONTAINING HIGH CHAIN-LENGTH POLYAMIDES ARKEMA INC. (US) 2008-05-22 WO disclosed
US-20080095806-A1 Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors PROMETIC BIOSCIENCES, INC. (CA) 2008-04-24 US disclosed
WO-2005117955-A1 TREATMENT OF ATOPIC DERMATITIS WITH UNGLYCOSYLATED ALPHA ONE-ANTITRYPSIN ARRIVA PHARMACEUTICALS, INC. (US) 2005-12-15 WO disclosed
EP-1562621-A1 COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISEASES USING PROTEASE INHIBITORS Arriva-Prometic Inc. (CA) 2005-08-17 EP disclosed
WO-2004045634-A1 COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISEASES USING PROTEASE INHIBITORS ARRIVA-PROMETIC INC. (CA) 2004-06-03 WO disclosed